首页>
外国专利>
Evaluation method for lymph node metastasis of endometrial cancer
Evaluation method for lymph node metastasis of endometrial cancer
展开▼
机译:子宫内膜癌淋巴结转移的评估方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Providing a technique for distinguishing between endometrial cancer and lymph node metastasis and non-metastasis at the molecular level. Endometrial cancer lymph comprising a step of measuring the expression level of one or more expression products of DNA including a transcription initiation region for a biological sample derived from cancer tissue isolated from a patient with endometrial cancer A method for evaluating node metastasis or lymph node metastasis ability, wherein the DNA is a base sequence represented by SEQ ID NOs: 1 to 277, from a base at an arbitrary position in a transcription initiation region and at least one base continuous downstream thereof The evaluation method, wherein the transcription initiation region is a region whose ends are defined by the first base of the base sequence represented by SEQ ID NOs: 1 to 277 and the 101st base from the 3 ′ end.
展开▼
机译:提供在分子水平上区分子宫内膜癌和淋巴结转移与非转移的技术。子宫内膜癌淋巴瘤,包括测量一种或多种DNA的表达水平的步骤,该DNA包括从子宫内膜癌患者体内分离出的癌组织衍生的生物样品的转录起始区,用于评估淋巴结转移或淋巴结转移能力,其中,DNA是由SEQ ID NO:1至277表示的碱基序列,从转录起始区中任意位置的碱基及其至少一个连续下游的碱基开始。评价方法,其中转录起始区为区域其末端由SEQ ID NO:1至277表示的碱基序列的第一个碱基和从3'末端开始的第101个碱基定义。
展开▼